Lu Ke

Institution
Chinese Academy of Sciences

Country
China

Field
Materials Sciences

Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.

(Photo: Future Science Prize)

AWARDS
  • Future Science Prize 2020

Related articles

Tai Chi Can Improve Survival Rate of Advanced Lung Cancer Patients By A Year

The study found that tai chi can also help cancer patients sleep better.

An Eye On AI

Backed by immense computing power, breakthroughs in AI are transforming multiple facets of society, from the way we deliver patient care to how we harness renewable energy resources like solar power.

Hot Centers

The Urban Heat Island effect is making densely populated areas in cities hotter. How are city planners and governments in Asia addressing this?

Supporting Women In STEM

As part of a continuing effort to bridge the gender gap for women scientists, L’Oréal Singapore celebrated three outstanding women researchers in the L’Oréal-UNESCO For Women in Science 2023 program. Dr Leow Wan Ru, Dr Yang Le and Dr Xue Shifeng each received S$10,000 to advance their research.

Defining The Future Of AI

In an interview with Supercomputing Asia, Torsten Hoefler, director, Scalable Parallel Computing Laboratory at ETH Zurich, covers HPC education, regulation and international collaboration.

Human Brains May Have Evolved To Innately Love Music

In a study, scientists in South Korea found that human brains develop a natural sensitivity to music, even before ever being exposed to it.

The Oceans Are Running A Fever

Increasing marine heatwaves are breaking the resilience of aquatic life with long-term consequences for coastal communities.

Accelerating Advancements In Healthcare

From disease diagnostics to drug development, healthcare applications are poised to receive a major boost from the combined power of AI and supercomputing.

Gum Disease Might Be A Precursor To Diabetes

Study shows how gum disease and diabetes interact. It suggests that "RESISTIN" molecule can be targeted to treat gum disease patients and reduce diabetes risk